Vice President, Development and Co-Founder
Pharmaceutical Sciences
Albireo Pharma
Sweden
Per-Göran Gillberg has proven expertise and a track record of success in the Swedish pharmaceutical industry, with over 25 years of experience at Pharmacia, Kabi and AstraZeneca. He has industry experience covering drug discovery and development through to marketed products. In particular, he played an instrumental role in the preclinical and clinical development of tolterodine, a marketed treatment for urinary incontinence
Clinical Research, Pharmaceutical Sciernces